- Home
- DSGN vs PFIS Comparison
DSGN vs PFIS Comparison
Compare DSGN & PFIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DSGN | PFIS |
|---|---|---|
| Founded | 2017 | 1905 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 579.9M | 499.8M |
| IPO Year | 2021 | 1998 |
Fundamental Metrics
Financial Performance| Metric | DSGN | PFIS |
|---|---|---|
| Price | $10.28 | $50.76 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | $15.25 | ★ $56.00 |
| AVG Volume (30 Days) | ★ 242.4K | 29.4K |
| Earning Date | 03-09-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 4.94% |
| EPS Growth | N/A | ★ 493.94 |
| EPS | N/A | ★ 5.88 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $12.01 |
| Revenue Next Year | N/A | $5.85 |
| P/E Ratio | ★ N/A | $8.63 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.62 | $39.00 |
| 52 Week High | $11.23 | $57.71 |
Technical Indicators
Market Signals| Indicator | DSGN | PFIS |
|---|---|---|
| Relative Strength Index (RSI) | 50.78 | 34.64 |
| Support Level | $9.64 | $46.14 |
| Resistance Level | $11.14 | $53.27 |
| Average True Range (ATR) | 0.59 | 1.86 |
| MACD | 0.03 | -0.42 |
| Stochastic Oscillator | 42.21 | 6.58 |
Price Performance
Historical ComparisonAbout DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About PFIS Peoples Financial Services Corp.
Peoples Financial Services Corp is a bank holding company operating through its subsidiaries. The bank provides a full range of financial services. Its products and services include checking accounts, business accounts, savings accounts, loan products, money market accounts, mortgages, chip-enabled debit cards, credit card processing, and visa master card and advisory services. Its loan portfolio includes Commercial loans, which consist of commercial, commercial real estate, municipal, and other related tax-free loans; and retail loans, which include residential real estate and other consumer loans. The company mainly operates in the United States in Pennsylvania.